Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FR13S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,008
Award facts
- Contract value 100% obligated
- $60,007.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $60,007.81 on January 28, 2026, for the supply of SKYRIZI 150 MG/ML in pen form. This competitive award, with no set-aside designation, represents a firm fixed-price delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania, with completion anticipated by January 29, 2026. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order supports the Defense Logistics Agency's Medical Supply Chain mission, which provides critical pharmaceutical and medical supplies to military treatment facilities, the Defense Health Agency, and other federal healthcare programs worldwide. SKYRIZI, a specialty pharmaceutical product, is part of the comprehensive medication portfolio that Amerisourcebergen supplies through its $999,999,999.00 prime contract with DLA Troop Support Medical running through December 2026. The company's federal contracting history demonstrates consistent capability in fulfilling competitive procurements for diverse pharmaceutical products across multiple therapeutic domains essential to military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FR13S?
SPE2DR26FR13S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FR13S worth?
The government has obligated $60,008 on SPE2DR26FR13S.
Is contract SPE2DR26FR13S an order under another contract?
Yes. SPE2DR26FR13S is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR13S competed?
The extent of competition for SPE2DR26FR13S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award